Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis

Background: Cholestasis is a reduction or cessation of bile flow in the biliary system, which can be life-threatening. Dimethyl Fumarate could induce anti-inflammatory and antioxidant effects in the body. Objective: This investigation focused on assessing the impact of Dimethyl Fumarate on liver lev...

Full description

Saved in:
Bibliographic Details
Main Authors: Hannaneh Vossoughi, Pejman Mortazavi, Mahsa Ale-Ebrahim, Razieh Hosseini
Format: Article
Language:English
Published: Elsevier 2025-12-01
Series:Toxicology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214750025002343
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225315285467136
author Hannaneh Vossoughi
Pejman Mortazavi
Mahsa Ale-Ebrahim
Razieh Hosseini
author_facet Hannaneh Vossoughi
Pejman Mortazavi
Mahsa Ale-Ebrahim
Razieh Hosseini
author_sort Hannaneh Vossoughi
collection DOAJ
description Background: Cholestasis is a reduction or cessation of bile flow in the biliary system, which can be life-threatening. Dimethyl Fumarate could induce anti-inflammatory and antioxidant effects in the body. Objective: This investigation focused on assessing the impact of Dimethyl Fumarate on liver levels of transforming growth factor beta (TGF-β) to mitigate biochemical, histopathological, and immunohistochemical alterations in cholestasis-induced rat models. Methods: Forty male adult Wistar rats were divided into eight groups (healthy control treated with distilled water, healthy rats treated with 50, 100, and 200 mg/kg of Dimethyl Fumarate, bile duct ligation (BDL), and experiment BDL groups were treated with 50, 100, and 200 mg/kg of Dimethyl Fumarate). After the gavage treatment period of 45 days, the rats were anesthetized and underwent blood sampling. Liver damage was assessed by measuring hepatic marker enzymes (alanine transaminase, aspartate transaminase, alkaline phosphatase, gamma-glutamyl transferase, and total bilirubin), histopathological (lesion assessment), and immunohistochemical (TGF-β expression level) observation. Results: The findings demonstrated that administration of varying doses of Dimethyl Fumarate via gavage led to a statistically significant reduction in serum concentrations of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, and total bilirubin (P < 0.05). The optimal dosage identified was 200 mg/kg of Dimethyl Fumarate. Furthermore, the data indicated that gavage treatment with Dimethyl Fumarate significantly attenuated TGF-β expression level and mitigated hepatic damage (P < 0.05). Conclusion: This strategy may reduce inflammation, cholestasis, and fibrosis outcomes, attributed to its anti-inflammatory and antioxidant properties. Nonetheless, further research is necessary to substantiate these findings.
format Article
id doaj-art-2d77174ca34e4fa984e690de269139d8
institution Kabale University
issn 2214-7500
language English
publishDate 2025-12-01
publisher Elsevier
record_format Article
series Toxicology Reports
spelling doaj-art-2d77174ca34e4fa984e690de269139d82025-08-25T04:14:27ZengElsevierToxicology Reports2214-75002025-12-011510211510.1016/j.toxrep.2025.102115Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasisHannaneh Vossoughi0Pejman Mortazavi1Mahsa Ale-Ebrahim2Razieh Hosseini3Faculty of Veterinary Sciences, SR.C., Islamic Azad University, Tehran, IranDepartment of Veterinary Pathobiology, SR.C., Islamic Azad University, Tehran, Iran; Corresponding author.Department of Physiology, TMS.C.,Islamic Azad University, Tehran, IranDepartment of Veterinary Basic Sciences, SR.C., Islamic Azad University, Tehran, IranBackground: Cholestasis is a reduction or cessation of bile flow in the biliary system, which can be life-threatening. Dimethyl Fumarate could induce anti-inflammatory and antioxidant effects in the body. Objective: This investigation focused on assessing the impact of Dimethyl Fumarate on liver levels of transforming growth factor beta (TGF-β) to mitigate biochemical, histopathological, and immunohistochemical alterations in cholestasis-induced rat models. Methods: Forty male adult Wistar rats were divided into eight groups (healthy control treated with distilled water, healthy rats treated with 50, 100, and 200 mg/kg of Dimethyl Fumarate, bile duct ligation (BDL), and experiment BDL groups were treated with 50, 100, and 200 mg/kg of Dimethyl Fumarate). After the gavage treatment period of 45 days, the rats were anesthetized and underwent blood sampling. Liver damage was assessed by measuring hepatic marker enzymes (alanine transaminase, aspartate transaminase, alkaline phosphatase, gamma-glutamyl transferase, and total bilirubin), histopathological (lesion assessment), and immunohistochemical (TGF-β expression level) observation. Results: The findings demonstrated that administration of varying doses of Dimethyl Fumarate via gavage led to a statistically significant reduction in serum concentrations of alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase, gamma-glutamyl transferase, and total bilirubin (P < 0.05). The optimal dosage identified was 200 mg/kg of Dimethyl Fumarate. Furthermore, the data indicated that gavage treatment with Dimethyl Fumarate significantly attenuated TGF-β expression level and mitigated hepatic damage (P < 0.05). Conclusion: This strategy may reduce inflammation, cholestasis, and fibrosis outcomes, attributed to its anti-inflammatory and antioxidant properties. Nonetheless, further research is necessary to substantiate these findings.http://www.sciencedirect.com/science/article/pii/S2214750025002343Dimethyl FumarateBile Duct LigationCholestasisTGF-β
spellingShingle Hannaneh Vossoughi
Pejman Mortazavi
Mahsa Ale-Ebrahim
Razieh Hosseini
Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis
Toxicology Reports
Dimethyl Fumarate
Bile Duct Ligation
Cholestasis
TGF-β
title Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis
title_full Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis
title_fullStr Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis
title_full_unstemmed Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis
title_short Evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation-induced cholestasis
title_sort evaluation of the effects of dimethyl fumarate on transforming growth factor beta levels in the liver of rats with bile duct ligation induced cholestasis
topic Dimethyl Fumarate
Bile Duct Ligation
Cholestasis
TGF-β
url http://www.sciencedirect.com/science/article/pii/S2214750025002343
work_keys_str_mv AT hannanehvossoughi evaluationoftheeffectsofdimethylfumarateontransforminggrowthfactorbetalevelsintheliverofratswithbileductligationinducedcholestasis
AT pejmanmortazavi evaluationoftheeffectsofdimethylfumarateontransforminggrowthfactorbetalevelsintheliverofratswithbileductligationinducedcholestasis
AT mahsaaleebrahim evaluationoftheeffectsofdimethylfumarateontransforminggrowthfactorbetalevelsintheliverofratswithbileductligationinducedcholestasis
AT raziehhosseini evaluationoftheeffectsofdimethylfumarateontransforminggrowthfactorbetalevelsintheliverofratswithbileductligationinducedcholestasis